Their vaccines are 90 percent capable of preventing coronavirus. That's what pharmaceutical company Pfizer and Bioentech claimed. The company said in a statement that it had obtained information from a preliminary test of its third trial. Multiple vaccines are in the third phase trial phase. Pfizer was the first to make such a claim.

The German company Bioentech has teamed up with Pfizer to develop the corona vaccine. The vaccine was administered to 43,000 people in six countries. The company claims that the question of whether tickers are safe at this stage has not yet been raised. Pfizer is also due to apply later this month for urgent approval to produce the vaccine.

Pfizer's announcement was welcomed by a section of the expert community. They are 'confident' about Pfizer's vaccine. At the same time, another part is giving a warning. However, most hope that this 'neonermal' episode will end next spring.

According to the agency, trials of the vaccine were underway in the United States, Germany, Brazil, Argentina, South Africa and Turkey. Pfizer claims to be 90 percent successful 7 days after the second dose. Albert Borla, chairman of Pfizer, said: "We are very close to tackling this global health crisis."

Pfizer says only a few people will be vaccinated this year. However, if approved, they will be able to make 50 million doses by the end of this year. At the end of 2021, it is possible to make 1.3 billion doses of the vaccine, the two companies said. However, it is not expected that everyone will get the vaccine. Preference will be given to those who are literally engaged in a 'frontal war' against Corona. However, the final decision will be taken by the government of the country concerned. It is believed that the vaccine will be given to those under the age of 50 and those who do not have any co-morbidity.